Search
EHA-PTHiT Mini Hematology Tutorial
EHA and the Polish Society of Hematology and Transfusion (PTHiT) are happy to present the second virtual 'mini Tutorial'. This two-day meeting aims to assess and increase your knowledge of the treatment of myeloid and lymphoid diseases.
Read moreEHA Lymphoma Group
The EHA Lymphoma Group (EHA LyG) is a specialized working group that was established in 2014.
Read moreHemaSphere, the Official Journal of the European Hematology Association, Receives Its First Impact Factor
The Hague, June 2022 - HemaSphere, the official peer-reviewed journal of the European Hematology Association (EHA), has received its first Journal Impact Factor™. The preliminary 2021 Journal Impact Factor for HemaSphere is 8.
Read morePediatric Hematology Online Forum
A bimonthly online event about complex cases that early-career doctors might encounter. What is the Pediatric Hematology Online Forum?The forum is an initiative of the Educational Subcommittee of the EHA SWG on Pediatric Hematology.
Read moreEHA and PTHiT Successfully Conclude the Second Joint Virtual Mini Hematology Tutorial
EHA-PTHiT Mini Hematology Tutorial
November 15-16, 2021
Meeting chairs:
Prof G Gaidano (European Hematology Association)
Prof I Hus (Polish Society of Hematology and Transfusion)
Prof T Robak (Polish Society of Hematology and Transfusion)
After a successful mini Tutorial in April 2021, EHA and PTHiT decided to…
Promising results in trials with non-chemotherapy treatments for Leukemias to be presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013
What is new? Current investigations are aimed at evaluating the use of monoclonal antibodies (mAB). These mABs bind to specific molecules (antigens) found on leukemic cells. This results in immune destruction of the leukemic cells.
Read moreCall for interest — EHA Exam Question Writers Group
The call for interest closed on October 7, 2024. EHA would like to appoint four new members of the European Hematology Exam Question Writers Group.
Read more